The starting dose varies by formulation, with R1 beginning at 3 mg and R2 at 1.5 mg daily for 30 days, allowing the body to adjust while minimizing gastrointestinal side effects
However, another study failed to prove any beneficial effect of low-dose hydrocortisone in the treatment of patients with COVID-19 (ref
F., Kochhar, P., Jasper, S., Brotherton, B., Orban, B., & Lulic, Z
Sun L, Zheng ZM, Shao CS, Zhang ZY, Li MW, Wang L, Wang H, Zhao GH, Wang P (2022) Rational design by structural biology of industrializable, long-acting antihyperglycemic GLP-1 receptor agonists
Ongoing monitoring through regular follow-up appointments tracks progress, assesses blood sugar levels, and ensures timely adjustments to your treatment plan
Oxidized low density lipoproteins in atherogenesis: role of dietary modification